Homology Medicines Inc
NASDAQ:QTTB
Homology Medicines Inc
NASDAQ:QTTB
Price:
6.68
USD
0.15%
Market Closed
Market Cap:
$97m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Homology Medicines Inc
NASDAQ:QTTB
|
US |
|
Davide Campari Milano NV
OTC:DVCMY
|
IT |
|
Recruit Holdings Co Ltd
TSE:6098
|
JP |
|
Y
|
Yokota Manufacturing Co Ltd
TSE:6248
|
JP |
|
IMC Pelita Logistik Tbk PT
IDX:PSSI
|
ID |
|
Takuma Co Ltd
TSE:6013
|
JP |
|
Air Water Inc
TSE:4088
|
JP |
|
Asetek A/S
OSE:ASTK
|
DK |
|
Canadian General Medical Centers Complex Company CJSC
SAU:9518
|
SA |
Balance Sheet
Balance Sheet Decomposition
Homology Medicines Inc
Homology Medicines Inc
Balance Sheet Decomposition is not available for
Homology Medicines Inc
Homology Medicines Inc
Balance Sheet
Homology Medicines Inc
Homology Medicines Inc
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
11
|
52
|
32
|
40
|
218
|
108
|
34
|
39
|
0
|
|
| Cash |
5
|
7
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Cash Equivalents |
6
|
44
|
32
|
40
|
217
|
108
|
34
|
39
|
0
|
|
| Short-Term Investments |
0
|
78
|
183
|
223
|
0
|
48
|
141
|
43
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Assets |
1
|
2
|
7
|
4
|
2
|
36
|
6
|
1
|
3
|
|
| Total Current Assets |
12
|
132
|
222
|
267
|
220
|
192
|
181
|
84
|
82
|
|
| PP&E Net |
2
|
3
|
36
|
43
|
43
|
18
|
22
|
1
|
7
|
|
| PP&E Gross |
2
|
3
|
36
|
43
|
43
|
18
|
22
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
1
|
2
|
8
|
16
|
6
|
6
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
26
|
0
|
3
|
|
| Other Long-Term Assets |
0
|
3
|
2
|
1
|
1
|
2
|
0
|
0
|
0
|
|
| Total Assets |
14
N/A
|
138
+868%
|
259
+88%
|
311
+20%
|
264
-15%
|
212
-20%
|
229
+8%
|
85
-63%
|
92
+9%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
3
|
16
|
3
|
5
|
2
|
1
|
3
|
3
|
|
| Accrued Liabilities |
1
|
3
|
5
|
8
|
12
|
12
|
20
|
8
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Other Current Liabilities |
4
|
4
|
2
|
2
|
6
|
3
|
1
|
0
|
3
|
|
| Total Current Liabilities |
6
|
9
|
23
|
12
|
23
|
17
|
23
|
12
|
16
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
|
| Other Liabilities |
0
|
30
|
40
|
40
|
45
|
25
|
28
|
0
|
61
|
|
| Total Liabilities |
7
N/A
|
39
+485%
|
63
+60%
|
52
-17%
|
68
+30%
|
42
-38%
|
51
+20%
|
12
-77%
|
87
+652%
|
|
| Equity | ||||||||||
| Common Stock |
17
|
138
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
10
|
40
|
96
|
200
|
328
|
424
|
429
|
542
|
235
|
|
| Additional Paid In Capital |
0
|
1
|
292
|
458
|
524
|
594
|
608
|
615
|
240
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
8
N/A
|
98
+1 211%
|
196
+100%
|
259
+32%
|
196
-24%
|
170
-13%
|
178
+5%
|
73
-59%
|
6
-92%
|
|
| Total Liabilities & Equity |
14
N/A
|
138
+868%
|
259
+88%
|
311
+20%
|
264
-15%
|
212
-20%
|
229
+8%
|
85
-63%
|
92
+9%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
36
|
36
|
37
|
45
|
50
|
57
|
58
|
3
|
12
|
|
Switch to:
Switch to:
See Also
Discover More
